| Literature DB >> 33997812 |
Nobuyuki Okahashi1,2, Masahiro Ueda1,3, Shu Yasuda1, Hiroshi Tsugawa1,4,5, Makoto Arita1,5,6.
Abstract
We describe a protocol for identifying bacteria-derived lipid metabolites produced in the guts using antibiotic-treated mice, liquid chromatography tandem mass spectrometry-based lipidomics, and feature-based molecular spectrum networking (FBMN). Untargeted lipidomics using the MS-DIAL 4 program provides information on known and unknown complex lipid molecules. The FBMN technique clusters similar MS2 spectra, facilitating the identification of bacterial lipids. Targeted analysis was used as a complementary method to cover oxylipins. Here, we provide details for targeted and untargeted analyses. For complete details on the use and execution of this protocol, please refer to Yasuda et al. (2020).Entities:
Keywords: Immunology; Mass Spectrometry; Metabolomics; Microbiology
Mesh:
Substances:
Year: 2021 PMID: 33997812 PMCID: PMC8091925 DOI: 10.1016/j.xpro.2021.100492
Source DB: PubMed Journal: STAR Protoc ISSN: 2666-1667
Q-TOF/MS parameter settings
| Parameters | Values |
|---|---|
| Ionization | Electrospray ionization |
| MS1 and MS2 mass ranges | |
| MS1 accumulation time | 250 ms |
| MS2 accumulation time | 100 ms |
| Cycle time | 1300 ms |
| Collision gas | Nitrogen |
| Collision energy (positive mode / negative mode) | +40/−42 eV |
| Collision energy spread | 15 eV |
| Ion source gas 1 (air; positive mode / negative mode) | 40/50 psi |
| Ion source gas 2 (air; positive mode / negative mode) | 80/50 psi |
| Curtain gas (nitrogen) | 30 psi |
| Ion source temperature (positive mode / negative mode) | 250°C/300°C |
| Ion spray voltage floating (positive mode / negative mode) | 5500/−4500 V |
| Declustering potential (positive mode / negative mode) | 80/−80 eV |
LC gradient condition for untargeted analysis
| Time (min) | Gradient (% B) | Flow rate (mL/min) |
|---|---|---|
| 0.0 | 0 | 0.3 |
| 1.0 | 0 | 0.3 |
| 5.0 | 40 | 0.3 |
| 7.5 | 64 | 0.3 |
| 12.0 | 64 | 0.3 |
| 12.5 | 82.5 | 0.3 |
| 19.0 | 85 | 0.3 |
| 20.0 | 95 | 0.3 |
| 20.1 | 0 | 0.3 |
| 25.0 | 0 | 0.3 |
TripleQ/MS parameter settings
| Parameters | Values |
|---|---|
| Ionization | Electrospray ionization |
| Collision gas (nitrogen) | Medium |
| Curtain gas (nitrogen) | 30 psi |
| Ion source gas 1 (air) | 15 psi |
| Ion source gas 2 (air) | 50 psi |
| Ion source temperature | 450°C |
| Ion spray voltage floating | −4500 V |
| MRM channels | Described in Data S1 |
LC gradient condition for targeted analysis
| Time (min) | Gradient (% B) | Flow rate (mL/min) |
|---|---|---|
| 0 | 27 | 0.05 |
| 5 | 27 | 0.05 |
| 15 | 70 | 0.05 |
| 25 | 80 | 0.05 |
| 30 | 80 | 0.08 |
| 33 | 80 | 0.10 |
| 35 | 95 | 0.10 |
| 39 | 100 | 0.10 |
| 40 | 27 | 0.05 |
| 47 | 27 | 0.05 |
Figure 1An overview of the procedures
Figure 2A workflow of fecal sample homogenization
Figure 3A workflow of single phase extraction
Parameter settings for MS-DIAL
| Section | Parameter | Value |
|---|---|---|
| Data collection | RT begin | 0.5 min |
| RT end | 18.0 min | |
| Mass range begin (MS1&2) | 0 Da | |
| Mass range end (MS1&2) | 2,000 Da | |
| MS1 mass tolerance | 0.01 Da | |
| MS2 mass tolerance | 0.025 Da | |
| Number of threads | 2 | |
| Peak detection | Minimum peak height | 500 amplitude |
| Mass slice width | 0.1 Da | |
| Smoothing level | 3 scans | |
| Minimum peak width | 5 scans | |
| Identification | Retention time tolerance | 2 min |
| MS1 mass tolerance | 0.01 Da | |
| MS2 mass tolerance | 0.05 Da | |
| Identification score cutoff | 80% | |
| Retention time for scoring | True | |
| Retention time for filtering | True | |
| Targeted lipid subclasses | Check all | |
| Alignment | Retention time tolerance | 0.05 min |
| MS1 mass tolerance | 0.015 Da | |
| Remove features based on blank information | TRUE |
Figure 4A MS-DIAL analysis screen
Figure 5A curation example of fatty acid annotations
The molecules of free fatty acids often provide no informative MS/MS spectrum for the structure characterization. Therefore, the confirmation of retention time is essential. Since the elution of free fatty acids in C18 column highly depends on the carbon- and desaturation properties, the mis-annotation can be identified by checking the elution behaviors. This figure shows one mis-annotation of FA 20:0 (marked as False 20:0) having the unexpected retention time value when considered to the other FA peaks' behaviors.
Figure 6A Cytoscape screen of molecular spectrum networking
Figure 7Expected outcomes
(A) The levels of microbiome-derived oxylipins were decreased in Abx-treated mice feces. The results are the mean ± SEM (n=5).
(B) Molecular spectrum networking results. Nodes corresponding to molecular species are linked based on the similarity of MS/MS spectra (similarity cut-off [%] = 85 in step 26-b). The nodes of circle and up- and down-arrows represent lipid ions with less than 10-fold changes and over 10-fold increases and decreases, respectively, in the Abx-treatment group compared to the control group. The node size and thickness of the links denote the magnitude of measured ion intensity and Bonanza score, respectively. Nomenclatures of identified lipids are listed in http://prime.psc.riken.jp/compms/msdial/lipidnomenclature.html. Both figures were generated from Yasuda et al., (2020).
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Acetonitrile for QTofMS | FUJIFILM Wako Pure Chemical | 018-26225 |
| Methanol for QTofMS | FUJIFILM Wako Pure Chemical | 130-18545 |
| 2-Propanol for QTofMS | FUJIFILM Wako Pure Chemical | 164-27515 |
| 1 mol/L Ammonium acetate solution | FUJIFILM Wako Pure Chemical | 018-21041 |
| Ethylenediamine- | Dojindo Laboratories | 346-01971 |
| APCI Positive Calibration Solution | SCIEX | 4460131 |
| APCI Negative Calibration Solution | SCIEX | 4460134 |
| Chloroform | MilliporeSigma | 05-3450-7-1L-J |
| EquiSPLASH LIPIDOMIX Quantitative Mass Spec Internal Standard | Avanti Polar Lipids | 330731-1EA |
| Acetonitrile for LCMS | FUJIFILM Wako Pure Chemical | 018-19853 |
| Methanol for LCMS | FUJIFILM Wako Pure Chemical | 134-14523 |
| Milli-Q water (18 MΩ) | Merck | n/a |
| Acetic acid LC-MS CHROMASOLV | FLUKA | 49199-50ML-F |
| Prostaglandin E2-d4 | Cayman | 314010 |
| Leukotriene B4-d4 | Cayman | 320110 |
| Leukotriene D4-d5 | Cayman | 10006199 |
| 15-Hydroxyeicosatetraenoic acid-d8 | Cayman | 334720 |
| Arachidonic acid-d8 | Cayman | 390010 |
| 14, 15-Epoxy-5, 8, 11-eicosatrienoic acid-d11 | Cayman | 10006410 |
| Prostaglandin B2-d4 | Cayman | 311210 |
| 8-iso Prostaglandin F2α-d4 | Cayman | 316350 |
| Analyst | SCIEX | Ver. 1.8.1 |
| Binary Solvent Manager | Waters | Ver. 1.72 |
| MassLynx | Waters | Ver. 4.2 |
| MultiQuant | SCIEX | Ver. 3.0.3 |
| MS-DIAL 4 | Tsugawa et al., (2020) | |
| Analysis Base File Converter | Reifycs | |
| Cytoscape | Cytoscape Consortium | |
| ACQUITY UPLC system | Waters | I class |
| Acquity UPLC Peptide BEH C18 column (50 × 2.1 mm; 1.7 μm) | Waters | 186003554 |
| TripleTOF 6600 mass spectrometer | SCIEX | n/a |
| Multiposition microelectric valve actuators | VICI Valco Instruments | EPC10W |
| Triple Quad 5500 QTrap mass spectrometer | SCIEX | n/a |
| Acquity UPLC BEH C18 column (150 × 1.0 mm; 1.7 μm) | Waters | 186002347 |
| Multi-beads shocker MB1200 | Yasui Kikai | n/a |
| 3 mL Metal corn beads | Yasui Kikai | MC-0316(S) |
| 3 mL Reinforced homogenization tubes | Yasui Kikai | ST-0320PCF |
| 200 μL Large orifice pipette tips | Scientific Specialties | 4297-S0 |
| 2.0 mL Glass jacket tubes | FCR&Bio | JRD-1GS200 |
| 2.0 mL Glass jacket tube caps | FCR&Bio | GC2-1S(HI) |
| MonoSpin C18-AX | GL Sciences | 5010-21736 |
| Glass tips for 0.2 mL | SIBATA SCIENTIFIC TECHNOLOGY | 080130-10021A |
| Dispensing Burette Glass DIGIFIT 0.2 mL | SIBATA SCIENTIFIC TECHNOLOGY | 080130-1002 |
| Disposable Pasteur Pipettes 5 inch | IWAKI | IK-PAS-5P |
| Acura manual 835 Macropipette with Pasteur pipette adapter 0.2 – 2 mL | Socorex | 835.02PP |
| 2 mL Screw Agilent Hplc Vials | Agilent | 5182-0716 |
| 250 μL Glass insert, deactivated | Agilent | 5181-8872 |
| Blue screw cap, pre-slit PTFE/sil septa | Agilent | 5185-5865 |
| Reagent | Final concentration | Amount |
|---|---|---|
| Ampicillin | 1 g/L | 500 mg |
| Vancomycin | 0.5 g/L | 250 mg |
| Neomycin | 1 g/L | 500 mg |
| Metronidazole | 1 g/L | 500 mg |
| Milli-Q water | n/a | 500 mL |
| Reagent | Final concentration | Amount |
|---|---|---|
| EquiSPLASH | n/a | 1 mL |
| Methanol for QTofMS | n/a | 29 mL |
| Reagent | Final concentration | Amount |
|---|---|---|
| Acetonitrile for QTofMS | n/a | 100 mL |
| Methanol for QTofMS | n/a | 100 mL |
| Milli-Q water | n/a | 300 mL |
| 1 M ammonium acetate solution | 5 mM | 2.5 mL |
| 50 μM EDTA 2NH4 solution | 10 nM | 100 μL |
| Reagent | Final concentration | Amount |
|---|---|---|
| 2-Propanol for QTofMS | n/a | 400 mL |
| 1 M ammonium acetate solution | 5 mM | 2 mL |
| 50 μM EDTA 2NH4 solution | 10 nM | 80 μL |
| Reagent | Final concentration | Amount |
|---|---|---|
| 10 mg/L Arachidonic acid-d8 methanol solution | 320 μM (100 μg/L) | 10 μL |
| 10 mg/L Prostaglandin E2-d4 methanol solution | 281 μM (100 μg/L) | 10 μL |
| 10 mg/L Leukotriene B4-d5 methanol solution | 294 μM (100 μg/L) | 10 μL |
| 10 mg/L Leukotriene D4-d5 methanol solution | 199 μM (100 μg/L) | 10 μL |
| 10 mg/L 15-hydroxyeicosatetraenoic acid-d8 methanol solution | 304 μM (100 μg/L) | 10 μL |
| 10 mg/L 14, 15-epoxy-5, 8, 11-eicosatrienoic acid-d11 methanol solution | 302 μM (100 μg/L) | 10 μL |
| Methanol for LCMS | n/a | 940 μL |
| Reagent | Final concentration | Amount |
|---|---|---|
| 10 mg/L Prostaglandin B2-d4 methanol solution | 295 μM (100 μg/L) | 10 μL |
| 10 mg/L 8-iso Prostaglandin F2α-d4 methanol solution | 279 μM (100 μg/L) | 10 μL |
| Methanol for LCMS | n/a | 980 μL |
| Reagent | Final concentration | Amount |
|---|---|---|
| Milli-Q water | n/a | 500 mL |
| Acetic acid LC-MS CHROMASOLV | 0.1% (v/v) | 500 μL |
| Reagent | Final concentration | Amount |
|---|---|---|
| Acetonitrile for LCMS | n/a | 400 mL |
| Methanol for LCMS | n/a | 100 mL |